In 2011, it was proposed that gelomulide K (18), a diterpene, can induce PARP1 (poly(ADP-ribose) polymerase 1) hyperactivation, AIFM/AIF nuclear translocation and cytoprotective autophagy in cancer cells. Here, PARP1 is linked to cancer.